This was despite intense pressure and lobbying efforts in this regard by a section of the influential American businesses.
By taking such a decision, it is understood that the long-term strategic relationship with India, which US President Barack Obama has described as the defining partnership of the 21st century, prevailed over the short-term goal of addressing the issues of alleged violation of intellectual property rights inside India and Indian policies with regard to pharma sector, which has angered the strong American pharma lobby and a section of the US lawmakers.
US Trade Representative (USTR) Mike Froman is scheduled to testify on the Hill tomorrow, wherein he is expected to defend the Administration's decision on this issue.
In a statement, the USTR said in the coming months, it will redouble its efforts to seek opportunities for meaningful, sustained, and effective engagement on IP-related matters with the "new government", including at senior levels, the report said.
Also Read
"India remains on the Priority Watch List in 2014. In making this determination, the US recognises not only the concerns..., but also the critical role that meaningful, constructive, and effective engagement between India and the U S should play in resolving these concerns," US Trade Representative said in the 2014 Special 301 report.
Putting India at this point of time in the middle of elections, and weeks ahead of formation of the new government, would not serve any purpose and in fact would have an adverse impact on establishing a positive and constructive relationship with the new leadership in New Delhi, it was argued.
From day one of the Obama Administration, Froman - in his previous capacity as the Deputy National Security Advisor - has been a strong advocate of India US strategic relationship and has played a key role in the shaping the economic ties between the two countries in the last five year, during which the bilateral trade has increased significantly.